Hahn and colleagues already have evidence that similar modifications to p38, Src and some half-dozen other kinases also allow inducible activation of those enzymes' catalytic activities without ...

BIAL has reported the completion of the full dose regimen for the first subject in the multicentre Phase II ACTIVATE trial of the allosteric activator of beta-glucocerebrosidase (GCase), BIA 28 ...